MYOD1 and ovarian cancer: A potential causal association of rs1271572 with the risk of ovarian cancer is supported by the finding that it maps to the promoter of the ESR2 gene, near (−53 bp upstream) the AP-4/MyoD binding site [14], a region of predicted intense transcription factor binding that might influence gene expression [7].